McBride (MCB) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
19 Sep, 2025Executive summary
Reported strong financial results for the year ending June 2025, with continued improvement in profitability and operational performance.
Achieved fifth consecutive reporting period at new profit levels, supporting the reinstatement of annual dividends after five years, reflecting confidence in future growth.
Transformation programme delivering positive results, with £50m net benefits on track.
Maintained robust service levels, operational efficiency, and sustainability progress, positioning the business for future growth.
Achieved further progress toward strategic ambitions, with a stronger business profile and sustained profit levels.
Financial highlights
Revenue at £926.5m, up 0.7% at constant FX compared to FY24, with group revenues down £8.3m (1.9%) on actual basis.
Adjusted operating profit held at £66.1m, with adjusted EBITDA of £85.8m and margin steady at 9.3%.
Free cash flow reached £93.9m, with cash conversion at 109% and net debt reduced to £105.2m, debt cover at 1.2x, ahead of the 1.5x target.
ROCE maintained at 33%, significantly above the 25% target.
Recommended dividend of 3.0p per share for FY2025.
Outlook and guidance
Solid start to the new financial year, with volumes in line with expectations and a strong pipeline from recent tender wins and new product launches.
Focus remains on operational efficiency, transformation program delivery, and achieving midterm EBITDA target of 10%.
Leadership is considering investment options to support further scale and value creation, with strong financial position supporting medium-term investment and shareholder returns.
Private label market share remains at an all-time high, with robust customer partnerships.
Latest events from McBride
- Revenue and profitability rose, driven by private label growth and disciplined cost control.MCB
H1 202626 Feb 2026 - Profit growth, margin recovery, and lower net debt drive a confident outlook.MCB
H2 202420 Feb 2026 - Adjusted operating profit on track, with revenue and volume growth supporting future gains.MCB
Trading update20 Jan 2026 - Revenue up, net debt down, and contract manufacturing volumes surged 48.9%.MCB
H2 2025 TU16 Jul 2025 - Profit, cash flow, and private label growth enabled dividend plans amid ongoing transformation.MCB
H1 20256 Jun 2025